| Literature DB >> 35841466 |
Tianjing Yang1, Darryl Joy Juntila2,3, Naomichi Fujihara2, Takashi Inada2,4, Kohei Yoneda5, Iwane Suzuki6.
Abstract
Squalene has a wide range of applications in the industry sectors of dietary supplements, cosmetics, immunization, and pharmaceuticals. Yet, suitable organisms as the source of squalene are limited. It is reported that the thraustochytrid Aurantiochytrium sp. strain 18W-13a can accumulate high content of squalene. However, squalene production in this organism is fluctuated under various conditions and is not yet optimized for commercialization. In this organism, the mevalonate pathway supplies isopentenyl pyrophosphate, the initial substrate for squalene production. In this pathway, 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR) is the rate-limiting enzyme. We found that the HMGR activity had a strong positive correlation with the squalene contents in the strain. We constitutively expressed the HMGR in this organism and found that the transformant showed increased and stable production of squalene as well as carotenoids and biomass. These results clearly indicated that the HMGR expression is the bottleneck of squalene synthesis in Aurantiochytrium sp.Entities:
Keywords: Lipid; Metabolic engineering; Mevalonate pathway; Microbial metabolites; Thraustochytriales
Mesh:
Substances:
Year: 2022 PMID: 35841466 DOI: 10.1007/s10126-022-10139-7
Source DB: PubMed Journal: Mar Biotechnol (NY) ISSN: 1436-2228 Impact factor: 3.727